Cargando…
m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
Lung adenocarcinoma (LUAD) is the most frequent subtype of lung cancer worldwide. However, the survival rate of LUAD patients remains low. N6-methyladenosine (m(6)A) and long noncoding RNAs (lncRNAs) play vital roles in the prognostic value and the immunotherapeutic response of LUAD. Thus, discernin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8094594/ https://www.ncbi.nlm.nih.gov/pubmed/33996259 http://dx.doi.org/10.1016/j.omtn.2021.04.003 |